Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients

Neurological Sciences

Volumn 29, Issue SUPPL. 4, 2008, Pages

  Del Popolo, Giulio ^a   Panariello, Giovanni ^b   Corso, Francesca ^a   Scisciolo, Giuseppe ^a   Lombardi, Giuseppe ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Neurorehabilitation Clinic   (Italy)

Author keywords

Multiple sclerosis; Neurogenic lower urinary tract dysfunction

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ANAMNESIS; ARTICLE; CLINICAL ASSESSMENT; DRUG CHOICE; EARLY DIAGNOSIS; ELECTROSTIMULATION; FOLLOW UP; FUNCTION TEST; HUMAN; IMPAIRED BLADDER EMPTYING; INTERMITTENT CATHETERIZATION; KIDNEY SCINTISCANNING; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NEUROGENIC BLADDER; NEUROLOGIC EXAMINATION; QUALITY OF LIFE; UNSPECIFIED SIDE EFFECT; URINARY DYSFUNCTION; URINE RETENTION; URODYNAMICS;

HUMANS; MULTIPLE SCLEROSIS; URINARY BLADDER, NEUROGENIC;

EID: 58049195701     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-1042-y     Document Type: Article

References (25)

1. Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 161:743-757
2. Hinson JL, Boone TB (1996) Urodynamics and multiple sclerosis. Urol Clin North Am 23:475-481
3. DasGupta R, Fowler CJ (2002) Sexual and urological dysfunction in multiple sclerosis: Better understanding and improved therapies. Curr Opin Neurol 15:271-278
4. Wheeler JS, Siroky MB, Pavlakis AJ et al (1983) The changing neurourologic pattern of multiple sclerosis. J Urol 130:123
5. Bemelmans BL, Hommes OR, Van Kerrebroeck PE et al (1991) Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. J Urol 145:1219-1224
6. Rickwood AM (2002) Assessment and conservative management of the neuropathic bladder. Semin Pediatr Surg 11:108-119
7. Wyndaele JJ, Castro D, Madersbacher H et al (2005) Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. Health Publications, Plymouth, 1061-1162
8. Wein AJ (1998) Pathophysiology and categorization of voiding dysfunction. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ (eds) Campbell's urology, 7th Edn. WB Saunders, Philadelphia, 917-926
9. Krane RJ, Siroky MB (1979) Classification of neuro-urologic disorders. In: Krane RJ, Siroky MB (eds) Clinical neuro-urology. Little Brown, Boston, 143-158
10. Stöhrer M, Goepel M, Kondo A et al (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18:139-158
11. Weld KJ, Dmochowski RR (2000) Association of level of injury and bladder behavior in patients with posttraumatic spinal cord injury. Urology 55:490-494
12. Chancellor MB, Anderson RU, Boone TB (2006) Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil 85:536-545
13. Diokno A, Ingber M (2006) Oxybutynin in detrusor overactivity. Urol Clin N Am 33:439-445
14. Buyse G, Waldeck K, Verpoorten C et al (1998) Intravesical oxybutynin for neurogenic bladder dysfunction: Less systemic side effects due to reduced first pass metabolism. J Urol 160:892-896
15. Di Stasi SM, Giannantoni A, Navarra P et al (2001) Intravesical oxybutynin: Mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. J Urol 166:2232-2236
16. Christ KF, Kornhuber HH (1980) Treatment of neurogenic bladder dysfunction in multiple sclerosis by ultrasound-controlled bladder training. Arch Psychiatr Nervenkr 228:191-195
17. Yamanishi T, Yasuda K, Kamai T et al (2004) Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11:88-96
18. De Ridder D, Vermeulen C, Ketelaer P et al (1999) Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg 99:61-64
19. Ishigooka M, Hashimoto T, Hayami S et al (1996) Electrical pelvic floor stimulation: A possible alternative treatment for reflex urinary incontinence in patients with spinal cord injury. Spinal Cord 34:411-415
20. McClurg D, Ashe RG, Marshall K, Lowe-Strong AS (2006) Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: A randomized pilot study. Neurourol Urodyn 25:337-348
21. Primus G, Kramer G (1996) Maximal external electrical stimulation for treatment of neurogenic or non neurogenic urgency and/or urge incontinence. Neurourol Urodyn 15:187-194
22. Amarenco G, Ismael SS, Even-Schneider A et al (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210-2215
23. Hagerty JA, Richards I, Kaplan WE (2007) Intravesical electrotherapy for neurogenic bladder dysfunction: A 22-year experience. J Urol 178:1680-1683
24. Del Popolo G, Filocamo MT, Li Marzi V et al (2007) Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53:1013-1019
25. Petit H, Wiart L, Gaujard E et al (1998) Botulinum: A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36:91-94